# Array BioPharma

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/Array_BioPharma
> Markdown URL: https://mediated.wiki/source/Array_BioPharma.md
> Source: https://en.wikipedia.org/wiki/Array_BioPharma
> Source revision: 1354174782
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

{{Infobox company
| name = Array BioPharma
| type = [Subsidiary](/source/Subsidiary)
| traded_as = {{NASDAQ was|ARRY}}
| industry = [Oncology](/source/Oncology)<BR>[Medication](/source/Medication)
| founded = {{start date and age|1998}}
| founder = {{ubl|Drs. Tony Piscopio|Kevin Koch|David Snitman|K.C. Nicolaou}}
| hq_location_city = [Boulder, Colorado](/source/Boulder%2C_Colorado)
| hq_location_country = United States
| revenue = $173.8 million (2018)
| parent = [Pfizer](/source/Pfizer)
| website = {{URL|https://www.arraybiopharma.com/}}
}}
'''Array BioPharma''' is an American clinical stage, pharmaceutical company that focuses on [oncology](/source/oncology) [medication](/source/medication) headquartered in [Boulder, Colorado](/source/Boulder%2C_Colorado). The company is currently a subsidiary of [Pfizer](/source/Pfizer) after being acquired for $11 billion in 2019. 

==History==
In 1998, the company was founded by Drs. Tony Piscopio, Kevin Koch, David Snitman, and K.C. Nicolaou.<ref>{{Cite web|title=Co-Founder Of Array BioPharma, Inc. To Lead New Korean Out-Sourcing Chemistry Company|url=https://www.biospace.com/article/co-founder-of-array-biopharma-inc-to-lead-new-korean-out-sourcing-chemistry-company-/|access-date=2020-07-28|website=BioSpace|language=en-US}}</ref>

In November 2000, the company became a [public company](/source/public_company) via an [initial public offering](/source/initial_public_offering).<ref>{{cite news | url=https://money.cnn.com/2000/11/17/deals/ipos/ | archive-url=https://web.archive.org/web/20190810125456/https://money.cnn.com/2000/11/17/deals/ipos/ | url-status=dead | archive-date=August 10, 2019 | title=Array IPO up 17% | work=[CNN](/source/CNN) | date=November 17, 2000}}</ref>

In June 2019, [Pfizer](/source/Pfizer) acquired the company for approximately $11 billion.<ref>{{Cite web|title=Pfizer acquires Array BioPharma, valued at $11.4 billion|url=https://www.rappler.com/business/233335-pfizer-acquisition-array-biopharma/|access-date=2020-07-29|website=Rappler|date=18 June 2019 |language=en}}</ref>

== Discovery of FDA Approved Small Molecules ==

* '''[MEKTOVI](/source/Binimetinib)''' (Binimetinib) - selective MEK inhibitor - Approved 2018, acquired by [Pfizer](/source/Pfizer) 
* '''[TUKYSA](/source/Tucatinib)''' (Tucatinib) - HER2 inhibitor - Approved 2020, owned by [Seagen](/source/Seagen) (Seattle Genetics)
* '''[BRAFTOVI](/source/Encorafenib)''' (Encorafenib) - BRAF inhibitor - Approved 2018, acquired by [Pfizer](/source/Pfizer)
* '''[KRAZATI](/source/Adagrasib)''' (Adagrasib) - KRasG12C mutation inhibitor - Approved 2022, collaboration with [Mirati Therapeutics](/source/Mirati_Therapeutics) 
* '''[KOSELUGO](/source/Selumetinib)''' (Selumetinib) - MEK1/2 inhibitor - Approved 2020, licensed by [Astrazeneca](/source/AstraZeneca)
* '''[VITRAKVI](/source/Larotrectinib)''' (Larotrectinib) - TRK Inhibitor - Approved 2018, licensed by [Loxo Oncology (Eli Lilly)](/source/Eli_Lilly_and_Company)
* '''[https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-selpercatinib-medullary-thyroid-cancer-ret-mutation#:~:text=On%20September%2027%2C%202024%2C%20the,an%20FDA%2Dapproved%20test%2C%20who RETEVMO]''' (Selpercatinib) - RET inhibitor - Approved 2024, licensed by [Loxo Oncology (Eli Lilly)](/source/Eli_Lilly_and_Company)
* '''[GANOVO](/source/Danoprevir)''' (Danoprevir) - HCV Protease inhibitor - [https://pmc.ncbi.nlm.nih.gov/articles/PMC7368560/ Approved] 2018 (in China), licensed by [Roche](/source/Roche)

==References==
{{Reflist}}

{{Authority control}}

Category:1998 establishments in Colorado
Category:2000 initial public offerings
Category:2019 mergers and acquisitions
Category:American companies established in 1998
Category:Pharmaceutical companies established in 1998
Category:Biotechnology companies established in 1998
Category:Pharmaceutical companies of the United States
Category:Companies formerly listed on the Nasdaq
Category:Biotechnology companies of the United States
Category:Health care companies based in Colorado
Category:Companies based in Boulder, Colorado
Category:Pfizer
Category:Pharmaceutical companies

---
Adapted from the Wikipedia article [Array BioPharma](https://en.wikipedia.org/wiki/Array_BioPharma) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/Array_BioPharma?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.